TherapeuticsMD | TXMD - Cash And Equivalent


TherapeuticsMD reported 523K in Cash and Equivalent for its fiscal quarter ending in June of 2024.





Cash And Equivalent Change Date
AbbVie USD 10.77B 4.2B Sep/2026
Alterity Therapeutics Limited AUD 15.77M 9.56M Jun/2023
Cipla INR 16.59B 6.41B Sep/2026
Clal Biotechnology ILS 5.73M 1.71M Dec/2023
Compugen USD 10.28M 2.15M Jun/2026
CSL USD 2.16B 633M Jun/2025
Grifols EUR 979.78M 334.84M Dec/2024
Novo Nordisk DKK 21.13B 17.81B Mar/2026
Pfizer USD 1.82B 848M Sep/2026
TherapeuticsMD 523K 89K Jun/2024